ZA972599B - Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders. - Google Patents

Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders.

Info

Publication number
ZA972599B
ZA972599B ZA9702599A ZA972599A ZA972599B ZA 972599 B ZA972599 B ZA 972599B ZA 9702599 A ZA9702599 A ZA 9702599A ZA 972599 A ZA972599 A ZA 972599A ZA 972599 B ZA972599 B ZA 972599B
Authority
ZA
South Africa
Prior art keywords
liver disorders
pharmaceuticals
treatment
production
bradykinin antagonists
Prior art date
Application number
ZA9702599A
Other languages
English (en)
Inventor
Gerhard Breipohl
Stephan Henke
Jochen Knolle
Klaus Wirth
Max Hropot
Martin Bickel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA972599B publication Critical patent/ZA972599B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9702599A 1996-03-27 1997-03-26 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders. ZA972599B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19612067A DE19612067A1 (de) 1996-03-27 1996-03-27 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen

Publications (1)

Publication Number Publication Date
ZA972599B true ZA972599B (en) 1997-09-29

Family

ID=7789557

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702599A ZA972599B (en) 1996-03-27 1997-03-26 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders.

Country Status (24)

Country Link
US (1) US5863901A (zh)
EP (1) EP0797997B1 (zh)
JP (1) JP4185169B2 (zh)
KR (1) KR100453394B1 (zh)
CN (1) CN1164421A (zh)
AT (1) ATE297749T1 (zh)
AU (1) AU1651697A (zh)
BR (1) BR9701455A (zh)
CA (1) CA2200040A1 (zh)
CZ (1) CZ90797A3 (zh)
DE (2) DE19612067A1 (zh)
DK (1) DK0797997T3 (zh)
ES (1) ES2242973T3 (zh)
HR (1) HRP970171A2 (zh)
HU (1) HUP9700642A3 (zh)
ID (1) ID16413A (zh)
IL (1) IL120521A0 (zh)
NO (1) NO971453L (zh)
PL (1) PL319193A1 (zh)
PT (1) PT797997E (zh)
SI (1) SI0797997T1 (zh)
SK (1) SK39297A3 (zh)
TR (1) TR199700228A2 (zh)
ZA (1) ZA972599B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
WO2009155611A1 (en) * 2008-06-20 2009-12-23 Kinemed, Inc. Compositions for the treatment of fibrotic diseases or conditions
AU2018371186B2 (en) 2017-11-24 2022-05-12 Pharvaris Netherlands B.V. Novel bradykinin B2 receptor antagonists
AR118982A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
WO1989009230A1 (en) * 1988-03-25 1989-10-05 Administrators Of The Tulane Educational Fund Therapeutic peptides
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
WO1991009055A1 (en) * 1989-12-08 1991-06-27 Boston University Acylated bradykinin antagonists and uses therefor
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
WO1992017201A1 (en) * 1991-04-01 1992-10-15 Cortech, Inc. Bradykinin antagonists
ES2123556T3 (es) * 1991-04-19 1999-01-16 Scios Nova Inc Peptidos de tipo bradiquinina.
JPH07504155A (ja) * 1991-04-19 1995-05-11 シオス・ノヴァ・インコーポレイテット ブラジキニンアンタゴニストペプチド
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
FR2686343B1 (fr) * 1992-01-17 1994-03-11 Adir Cie Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW258739B (zh) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1994006453A1 (en) * 1992-09-11 1994-03-31 Stewart John M Bradykinin antagonists containing aliphatic amino acids in the 5-position
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
ATE191486T1 (de) * 1993-09-09 2000-04-15 Scios Inc Pseudo-oder nicht peptidartige bradykinin rezeptor antagoniste
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
DE69533704D1 (de) * 1994-03-09 2004-12-02 Cortech Inc Bradykinin-antagonist peptide mit n-substituierten glycinen

Also Published As

Publication number Publication date
HUP9700642A2 (hu) 1998-01-28
IL120521A0 (en) 1997-07-13
JP4185169B2 (ja) 2008-11-26
EP0797997A2 (de) 1997-10-01
AU1651697A (en) 1997-10-02
KR100453394B1 (ko) 2004-12-30
TR199700228A2 (xx) 1997-10-21
HU9700642D0 (en) 1997-05-28
DE59712344D1 (de) 2005-07-21
PT797997E (pt) 2005-09-30
EP0797997A3 (de) 2000-05-31
HRP970171A2 (en) 1998-04-30
DE19612067A1 (de) 1997-10-02
PL319193A1 (en) 1997-09-29
KR970064622A (ko) 1997-10-13
NO971453L (no) 1997-09-29
CA2200040A1 (en) 1997-09-27
SK39297A3 (en) 1997-10-08
ES2242973T3 (es) 2005-11-16
BR9701455A (pt) 1998-08-18
ID16413A (id) 1997-09-25
CZ90797A3 (en) 1997-10-15
NO971453D0 (no) 1997-03-26
US5863901A (en) 1999-01-26
HUP9700642A3 (en) 1998-03-02
DK0797997T3 (da) 2005-10-17
EP0797997B1 (de) 2005-06-15
JPH1017491A (ja) 1998-01-20
CN1164421A (zh) 1997-11-12
SI0797997T1 (en) 2005-10-31
ATE297749T1 (de) 2005-07-15
MX9702292A (es) 1997-09-30

Similar Documents

Publication Publication Date Title
IL128416A0 (en) Pharmaceutical composition for the treatment of alzheimer's disease
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
HU9701059D0 (en) Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis
BG102733A (en) New substituted cyclic amino acids as pharmaceutical forms
EP0379806A3 (en) Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
CA2260145A1 (en) Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1
CA2100212A1 (en) Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
WO1998025930A3 (en) Use of bi- and tricyclic pyridone derivatives against alzheimer's disease
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
WO1999040883A3 (en) Compositions and methods for the treatment of cystic fibrosis
NO975234L (no) Fremgangsmåte for behandling av maniske og bipolare forstyrrelser
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ZA972599B (en) Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders.
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
NZ303993A (en) Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
MY121604A (en) Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc together with azt
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
CA2260863A1 (en) Treatment of psychotic disorders
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
AU4016189A (en) Use of 2-azabicyclo(2.2.2) octane-3-carboxylic acid derivatives for the production of medicinal products intended for the treatment of diseases resulting from impairment of the vascular wall as well as for disorders of the microcirculation
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders
ZA974415B (en) Use of nonpeptide bradykinin antagonists for the treatment and prevention of chronic fibrogenetic liver disorders, acute liver disorders and the complications associated therewith.